Radiopharm Theranostics Limited
RADX
$7.03
-$0.42-5.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.10% | 13.91% | 6.63% | -11.89% | -34.81% |
| Total Depreciation and Amortization | -18.07% | 11.36% | 37.39% | 15.20% | -7.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -68.31% | -90.03% | -113.66% | -37.58% | 238.86% |
| Change in Net Operating Assets | -181.22% | -91.77% | 77.01% | 77.01% | 77.01% |
| Cash from Operations | -58.16% | -51.61% | -44.77% | -21.47% | 3.54% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 671.27% | 347.91% | 276.39% | 179.08% | 79.02% |
| Cash from Investing | 671.27% | 351.81% | 279.75% | 178.66% | 79.63% |
| Total Debt Issued | -- | -57.41% | 48.37% | 296.74% | -- |
| Total Debt Repaid | 63.23% | 26.24% | -38.19% | -212.34% | -- |
| Issuance of Common Stock | 82.08% | 300.98% | 3,370.56% | 745.27% | 194.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -302.67% | -759.48% | -5,707.09% | -942.55% | -93.10% |
| Cash from Financing | 49.91% | 243.18% | 3,240.51% | 757.31% | 221.35% |
| Foreign Exchange rate Adjustments | 120.12% | 693.85% | 440.11% | 37.26% | -110.39% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 56.54% | 393.57% | 253.09% | 209.40% | 144.38% |